Piramal Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
2,216.35
2,302.86
1,970.68
2,578.74
2,020.08
Other Income Qtr Cr12.1361.1119.5426.3861.51
Operating Revenues Qtr2,204.222,241.751,951.142,552.361,958.57

*All values are in Cr.

Operating Expenses Qtr
1,866.48
1,900.14
1,746.65
2,022.43
1,690.20
Operating Profit Qtr
337.74
341.61
204.49
529.93
268.37
EBIDT Qtr Cr
349.87
402.72
224.03
525.79
297.61
Depreciation Qtr
196.81
192.22
184.55
196.13
186.32
Net Profit Qtr
3.68
22.59
-88.64
101.27
10.11
Basic EPS Qtr
0.03
0.17
-0.67
0.77
0.08
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -